skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines NemolizumabQuestion & answer

Nemolizumab · Medicine question

Which receptor does nemolizumab target?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Nemolizumab selectively binds IL-31RA, inhibiting IL-31 signalling.

Sources for this answer

Nemluvio 30 mg powder and solvent for solution for injection in pre-filled penGalderma (U.K.) Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 3Document updated 8 May 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Nemolizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about Nemolizumab

Does nemolizumab significantly affect warfarin exposure in patients with moderate-to-severe atopic dermatitis?What does the prescribing information say about using nemolizumab during breastfeeding?What is the recommendation on using nemolizumab during pregnancy?What are the most common adverse reactions to Nemluvio in patients with prurigo nodularis?What is Nemluvio indicated for in adults with prurigo nodularis?What is the most common adverse reaction to Nemluvio in patients with atopic dermatitis?

Read the Nemolizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX